Mallinckrodt (MNK) Warns of Chapter 11 Filing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Mallinckrodt plc (MNK) PT Lowered to $2 at BMO Capital
August 4, 2020 12:50 PM EDTBMO Capital analyst Gary Nachman lowered the price target on Mallinckrodt plc (NYSE: MNK) to $2.00 (from $4.00) while maintaining a Market Perform rating.
The analyst commented, "2Q results overall were better than previously lowered expectations given COVID-19 and other pressures, but focus... More
Mallinckrodt (MNK) Tops Q2 EPS by 54c, Revenues Beat
August 4, 2020 6:09 AM EDTMallinckrodt (NYSE: MNK) reported Q2 EPS of $1.89, $0.54 better than the analyst estimate of $1.35. Revenue for the quarter came in at $700.9 million versus the consensus estimate of $635.33 million.
Second quarter net sales of $166.5 million net of the retrospective one-time Acthar® Gel Medicaid liability; adjusted net sales of $700.9 million, a decline of 14.9%, due primarily to demand impacts related to COVID-19 and competitive and payer pressures on certain productsDiluted loss per share of $11.04 with adjusted diluted earnings per share (EPS) of $1.89, a decline of 25.3%Operating cash flows of $170.9 million in the... More